UCB SA Revenue 2009-2017 | UCBJF

UCB SA annual/quarterly revenue history and growth rate from 2009 to 2017. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • UCB SA revenue for the quarter ending June 30, 2017 was $M, a NAN% increase year-over-year.
  • UCB SA revenue for the twelve months ending June 30, 2017 was $0M, a NAN% increase year-over-year.
  • UCB SA annual revenue for 2019 was $5.503B, a 0.59% increase from 2018.
  • UCB SA annual revenue for 2018 was $5.47B, a 6.84% increase from 2017.
  • UCB SA annual revenue for 2017 was $5.12B, a 10.75% increase from 2016.
UCB SA Annual Revenue
(Millions of US $)
2019 $5,503
2018 $5,470
2017 $5,120
2016 $4,623
2015 $4,304
2014 $4,445
2013 $4,531
2012 $4,452
2011 $4,521
2010 $4,273
2009 $4,346
2008 $5,298
2007 $4,970
UCB SA Quarterly Revenue
(Millions of US $)
2017-06-30
2016-12-31
2016-06-30
2015-12-31
2014-12-31
2014-06-30
2013-12-31
2012-12-31
2011-12-31
2010-12-31
2009-12-31
2008-12-31
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $15.687B $5.503B
UCB SA is a Belgium-based biopharmaceutical and specialty chemical company that specializes in providing therapy for central nervous system disorders, including epilepsy, diabetic neuropathic pain, sclerosis and Parkinson's disease. It also provides therapy in the areas of oncology, immunology, inflammation, allergy and respiratory diseases. UCB delivers small and large molecule solutions to specialists for use in the treatment of severe diseases.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $60.217B 34.83
Takeda Pharmaceutical (TAK) Japan $48.868B 8.56
Astellas Pharma (ALPMY) Japan $29.371B 14.67
Eisai (ESALY) Japan $20.251B 37.73
Grifols, S.A (GRFS) Spain $13.311B 16.55
Merck (MKGAF) Germany $12.924B 16.95
Ono Pharmaceutical (OPHLF) Japan $9.254B 19.78
Neurocrine Biosciences (NBIX) United States $8.419B 233.90
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $7.874B 0.00
Catalent (CTLT) United States $7.671B 31.56
Ionis Pharmaceuticals (IONS) United States $7.164B 21.71
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.906B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $5.937B 7.24
Orion OYJ (ORINY) Finland $5.269B 23.61
STADA ARZNEIMI (STDAF) Germany $4.685B 0.00
IPSEN SA ADR (IPSEY) France $4.656B 0.00
Forty Seven (FTSV) United States $4.599B 0.00
United Therapeutics (UTHR) United States $4.202B 0.00
Evotec AG (EVTCY) Germany $3.580B 57.74
Hypermarcas (HYPMY) Brazil $3.462B 10.53
Nektar Therapeutics (NKTR) United States $3.207B 0.00
FibroGen (FGEN) United States $3.159B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.942B 54.60
PTC Therapeutics (PTCT) United States $2.816B 0.00
ChemoCentryx (CCXI) United States $2.682B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.440B 9.87
Xencor (XNCR) United States $1.805B 73.70
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.684B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.593B 19.36
USANA Health Sciences (USNA) United States $1.511B 15.86
Sage Therapeutics (SAGE) United States $1.473B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.467B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.345B 36.78
Corcept Therapeutics (CORT) United States $1.322B 14.80
Karyopharm Therapeutics (KPTI) United States $1.255B 0.00
Heron Therapeutics (HRTX) United States $1.155B 0.00
Zogenix (ZGNX) United States $1.047B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.012B 31.34
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $0.940B 13.08
Akebia Therapeutics (AKBA) United States $0.921B 0.00
Esperion Therapeutics (ESPR) United States $0.879B 0.00
CLINIGEN GP (CLIGF) United Kingdom $0.759B 0.00
Endo (ENDP) Ireland $0.728B 1.34
Molecular Templates (MTEM) United States $0.632B 0.00
Tilray (TLRY) Canada $0.620B 0.00
Translate Bio (TBIO) United States $0.620B 0.00
ImmunoGen (IMGN) United States $0.607B 0.00
Radius Health (RDUS) United States $0.603B 0.00
Collegium Pharmaceutical (COLL) United States $0.602B 0.00
Aerie Pharmaceuticals (AERI) United States $0.557B 0.00
Portola Pharmaceuticals (PTLA) United States $0.552B 0.00
Siga Technologies (SIGA) United States $0.432B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.411B 16.86
Indivior (INVVY) United States $0.408B 2.43
Catalyst Pharmaceuticals (CPRX) United States $0.405B 13.52
Innate Pharma SA (IPHYF) France $0.385B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.376B 0.00
Ardelyx (ARDX) United States $0.376B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.360B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.329B 0.00
Trillium Therapeutics (TRIL) Canada $0.329B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.316B 0.00
Organogenesis Holdings (ORGO) United States $0.315B 0.00
Calithera Biosciences (CALA) United States $0.307B 0.00
Flexion Therapeutics (FLXN) United States $0.299B 0.00
Harpoon Therapeutics (HARP) United States $0.296B 0.00
Lannett Co Inc (LCI) United States $0.294B 4.73
DURECT (DRRX) United States $0.284B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.271B 0.00
Ocular Therapeutix (OCUL) United States $0.271B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.268B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.262B 0.00
TherapeuticsMD (TXMD) United States $0.251B 0.00
Concert Pharmaceuticals (CNCE) United States $0.249B 0.00
Rafael Holdings (RFL) United States $0.207B 0.00
CASI Pharmaceuticals (CASI) United States $0.192B 0.00
Recro Pharma (REPH) United States $0.187B 0.00
OptiNose (OPTN) United States $0.179B 0.00
Jounce Therapeutics (JNCE) United States $0.169B 3.04
PROFOUND MEDICL (PROF) Canada $0.166B 0.00
MEI Pharma (MEIP) United States $0.165B 0.00
Nature's Sunshine Products (NATR) United States $0.157B 19.61
La Jolla Pharmaceutical (LJPC) United States $0.156B 0.00
Taiwan Liposome (TLC) Taiwan $0.136B 0.00
KalVista Pharmaceuticals (KALV) United States $0.135B 0.00
Redhill Biopharma (RDHL) Israel $0.123B 0.00
VAXART, INC (VXRT) United States $0.122B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.104B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.102B 0.00
CannTrust Holdings (CTST) Canada $0.090B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.087B 0.00
IMV INC (IMV) Canada $0.087B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.085B 0.00
SCYNEXIS (SCYX) United States $0.082B 0.00
Champions Oncology (CSBR) United States $0.079B 0.00
Hemispherx BioPharma (AIM) United States $0.079B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.076B 0.00
Xeris Pharmaceuticals (XERS) United States $0.075B 0.00
Aquestive Therapeutics (AQST) United States $0.071B 0.00
CTI BioPharma (CTIC) United States $0.071B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.069B 0.00
Biomerica (BMRA) United States $0.069B 0.00
CV Sciences (CVSI) United States $0.067B 0.00
Otonomy (OTIC) United States $0.061B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.055B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.054B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.054B 16.86
Nivalis Therapeutics (ALPN) United States $0.051B 0.00
Infinity Pharmaceuticals (INFI) United States $0.050B 0.00
Onconova Therapeutics (ONTX) United States $0.048B 0.00
Aclaris Therapeutics (ACRS) United States $0.048B 0.00
PharmAthene (ALT) United States $0.046B 0.00
Natural Alternatives (NAII) United States $0.045B 20.31
Sundial Growers (SNDL) Canada $0.044B 0.00
GTx (ONCT) United States $0.044B 0.00
MediWound (MDWD) Israel $0.041B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.040B 135.43
Neos Therapeutics (NEOS) United States $0.039B 0.00
Forward Pharma (FWP) Denmark $0.038B 0.00
Iterum Therapeutics (ITRM) Ireland $0.037B 0.00
PolarityTE (PTE) United States $0.036B 0.00
AgeX Therapeutics (AGE) United States $0.035B 0.00
IsoRay (ISR) United States $0.034B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.031B 0.00
Heat Biologics (HTBX) United States $0.030B 0.00
ElectroCore (ECOR) United States $0.028B 0.00
Cardiome Pharma (CORV) Canada $0.025B 0.00
Jaguar Animal Health (JAGX) United States $0.025B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.024B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.024B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.024B 0.00
Mannatechorporated (MTEX) United States $0.023B 7.32
Adamis Pharmaceuticals (ADMP) United States $0.023B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.023B 0.00
ProPhase Labs (PRPH) United States $0.022B 0.00
Lipocine (LPCN) United States $0.021B 0.00
India Globalization Capital (IGC) United States $0.018B 0.00
Bio-Path Holdings (BPTH) United States $0.017B 0.00
Novan (NOVN) United States $0.017B 0.00
Can-Fite Biopharma (CANF) Israel $0.014B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.012B 0.00
Cyanotech (CYAN) United States $0.012B 0.00
Shineco (TYHT) China $0.011B 0.00
KemPharm (KMPH) United States $0.011B 0.00
Vical (BBI) United States $0.011B 0.00
China SXT Pharmaceuticals (SXTC) China $0.011B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.010B 0.00
Regulus Therapeutics (RGLS) United States $0.010B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.008B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.006B 0.00
Midatech Pharma (MTP) United Kingdom $0.006B 0.00
HANCOCK JAFFE (HJLI) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
RXi Pharmaceuticals (PHIO) United States $0.005B 0.00
Flex Pharma (SLRX) United States $0.003B 0.00